Historical Size and Value of the MENA Syringes and Cannula Market, with Import and Export Statistics to 2031

The MENA Syringes and Cannula market is expected to exceed US$ 1.2 billion in 2020, with a CAGR of close to 6.4% over the forecast period (2021-2031).

The rising popularity of elective medical procedures and surgeries, as well as rising medical supply consumption, are driving demand for low-cost equipment and healthcare supplies.

The COVID-19 pandemic increased hospitalisation rates, and demand for medical supplies such as syringes, cannulas, and personal protective medical equipment increased in the Middle East and North Africa. As overall medical supply consumption rises, the region is seeing a growing trend toward the use of syringes and cannulas, which is boosting the market.

Medical products such as syringes and cannulas are used in single-use cases to prevent the spread of infectious agents and contaminants to providers and patients. This factor shortens the average time spent using such products while increasing the demand for syringes and cannulas in medical settings.

"Rising diabetes incidence and growing preference for cosmetic surgeries among individuals are expected to create opportunities for growth in the MENA syringers & cannula market," according to an FMI analyst.  

Key Takeaways:

  • In 2020, the medical protective equipment segment accounted for 59.8% of the total market share.
  • In 2020, the disposables segment accounted for 87.3% of the MENA syringes & cannula market.
  • In terms of distribution channels, institutional sales are the dominant segment, accounting for approximately 63.8% of the total market share in 2020.
  • Saudi Arabia held 16.2% of the total market share in 2020, a trend that is expected to continue throughout the forecast period.

Competition Landscape

  • To gain a competitive advantage, key players in the MENA syringes & cannulas market are launching novel products. They are also expanding their footprint through mergers, acquisitions, and collaborations. As an example:
  • • In June 2021, Becton Dickinson and Company received an order for needles and syringes to participate in a vaccination drive in 40 countries, including Saudi Arabia, Germany, and South Africa. • In August 2021, Hindustan Syringes and Medical Devices Ltd met a milestone target of producing 1 billion auto-disposable syringes for COVID 19 vaccinations. The company now has the capacity to produce 50 crore AD syringes per year.

Want more insights?

Future Market Insights provides a comprehensive research report on forecasted revenue growth at the MENA, regional, and country levels, as well as an analysis of the most recent industry trends in each sub-segment from 2016 to 2030. The MENA syringes & cannula market is segmented in depth to cover every aspect of the market and provide the reader with a comprehensive market intelligence approach.

The study provides compelling insights into the product segmentation of the MENA syringes and cannula market (syringes [disposable hypodermic syringes, auto disposable syringes, safety syringes, prefilled syringes, and insulin syringes], cannulae [neonatal cannulae, straight cannulae, winged cannulae

Get Complete Report@
https://www.futuremarketinsights.com/reports/mena-syringes-and-cannula-market

Comments

Post a Comment

Popular posts from this blog

Global Medical face shield Market Insights and Outlook 2022-2032

Image
Medical face shield can become as ubiquitous as masks, as new findings on the airborne spread of Covid-19 influence behavior and guidelines. According to a latest study by Future Market Insights,  Medical Face Shields Market  will grow at over 11% CAGR through 2030. Medical face shields have proven to be an effective first-line defence against airborne diseases such as Zika, SARS, Ebola, flu, and now Covid-19. As a result, increased adoption of medical face shields, and thus increased production, is expected to drive the market during the forecast period. The IDSA (Infectious Diseases Society of America) has included the use of PPE (Personal Protective Equipment) such as face shields and masks in its recommendations. Though masks have been widely used throughout the world, their effectiveness is not widely known. The possibility of cloth masks providing marginal virus protection due to potential moisture retention, poor filtration, and re-use cannot be ruled out. Face ...
Read more

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasoun...
Read more

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more